Get the latest Science News and Discoveries
Blockbuster retatrutide trial signals a ‘new high-water mark’ for weight-loss drugs
The experimental weight-loss drug is a triple agonist and the first of its kind to reach a phase 3 clinical trial
None
Or read this on Scientific American
